Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Changes In Stockholders Equity (Unaudited) - USD ($)
Series H Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Series Seed Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 4,270,507 $ 279 $ 1,131,551 $ (5,293,951) $ 108,386
Balance, shares at Dec. 31, 2018 3,882,791 2,793,591      
Preferred Stock issued for Cash $ 1,656,374 1,656,374
Preferred Stock issued for Cash, shares 946,499      
Stock based compensation 131,443 131,443
Discount on Debt 69,174 69,174
Net Loss (1,263,089) (1,263,089)
Balance at Mar. 31, 2019 $ 5,926,881 $ 279 1,332,168 (6,557,040) 702,288
Balance, shares at Mar. 31, 2019 4,829,290 2,793,591      
Balance at Dec. 31, 2018 $ 4,270,507 $ 279 1,131,551 (5,293,951) 108,386
Balance, shares at Dec. 31, 2018 3,882,791 2,793,591      
Net Loss               (5,214,578)
Balance at Sep. 30, 2019 $ 7,147,944 $ 289 2,747,382 (10,508,529) (612,914)
Balance, shares at Sep. 30, 2019 5,483,684 2,894,374      
Balance at Mar. 31, 2019 $ 5,926,881 $ 279 1,332,168 (6,557,040) 702,288
Balance, shares at Mar. 31, 2019 4,829,290 2,793,591      
Preferred Stock issued for Cash $ 1,091,063 1,091,063
Preferred Stock issued for Cash, shares 589,394      
Stock based compensation 476,214 476,214
Net Loss (1,809,649) (1,809,649)
Balance at Jun. 30, 2019 $ 7,017,944 $ 279 1,808,382 (8,366,689) 459,916
Balance, shares at Jun. 30, 2019 5,418,684 2,793,591      
Preferred Stock issued for Cash $ 130,000 130,000
Preferred Stock issued for Cash, shares 65,000        
Common stock issued for Cash $ 10 360 370
Common stock issued for Cash, shares 100,783      
Stock based compensation 752,965 752,965
Discount on Debt 185,675 185,675
Net Loss (2,141,840) (2,141,840)
Balance at Sep. 30, 2019 $ 7,147,944 $ 289 2,747,382 (10,508,529) (612,914)
Balance, shares at Sep. 30, 2019 5,483,684 2,894,374      
Balance at Dec. 31, 2019 $ 9,025,245 $ 395 5,001,947 (13,958,644) 68,943
Balance, shares at Dec. 31, 2019 7,360,985 3,948,078      
Stock based compensation 156,459 156,459
Net Loss (1,795,153) (1,795,153)
Balance at Mar. 31, 2020 $ 9,025,245 $ 395 5,158,406 (15,753,797) (1,569,751)
Balance, shares at Mar. 31, 2020 7,360,985 3,948,078      
Balance at Dec. 31, 2019 $ 9,025,245 $ 395 5,001,947 (13,958,644) 68,943
Balance, shares at Dec. 31, 2019 7,360,985 3,948,078      
Net Loss               (6,006,735)
Balance at Sep. 30, 2020 $ 2,430 51,156,135 (20,398,106) 30,760,459
Balance, shares at Sep. 30, 2020 8 2,189 50 24,298,333      
Balance at Mar. 31, 2020 $ 9,025,245 $ 395 5,158,406 (15,753,797) (1,569,751)
Balance, shares at Mar. 31, 2020 7,360,985 3,948,078      
Conversion of AYRO Preferred Stock to common stock $ (9,025,245) $ 201 9,025,044
Conversion of AYRO Preferred Stock to common stock, shares (7,360,985) 2,007,193      
Issuance of Series Preferred Stock in connection with the 2020 Merger
Issuance of Series Preferred Stock in connection with the 2020 Merger, shares 8 2,189 7,883      
Issuance of Common Stock in connection with the 2020 Merger, net of fees $ 493 4,451,237 4,451,730
Issuance of Common Stock in connection with the 2020 Merger, net of fees, shares 4,939,045      
Exchange of debt for common stock in connection with the 2020 Merger $ 103 999,897 1,000,000
Exchange of debt for common stock in connection with the 2020 Merger, shares 1,030,585      
Issuance of common stock in connection with debt offering $ 56 461,957 462,013
Issuance of common stock in connection with debt offering, shares 553,330      
Sale of common stock, net of fees $ 220 5,064,780 5,065,000
Sale of common stock, net of fees, shares 2,200,000      
Exercise of warrants, net of fees $ 183 515,155 515,338
Exercise of warrants, net of fees, shares 1,831,733      
Stock based compensation 150,949 150,949
Net Loss (1,530,856) (1,530,856)
Balance at Jun. 30, 2020 $ 1,651 25,827,425 (17,284,653) 8,544,423
Balance, shares at Jun. 30, 2020 8 2,189 7,883 16,509,964      
Sale of common stock, net of fees $ 500 22,260,302 22,260,802
Sale of common stock, net of fees, shares 5,007,895      
Exercise of warrants, net of fees $ 254 2,467,936 2,468,190
Exercise of warrants, net of fees, shares 2,539,769      
Conversion of Series H-6 Preferred Stock $ 23 (23)
Conversion of Series H-6 Preferred Stock, shares (7,833) 225,590      
Stock based compensation 119,853 119,853
Vested restricted stock $ 2 47,915 47,917
Vested restricted stock, shares 15,115      
Deemed divided on mofification of H-5 warrants 432,727 (432,727)
Net Loss (2,680,726) (2,680,726)
Balance at Sep. 30, 2020 $ 2,430 $ 51,156,135 $ (20,398,106) $ 30,760,459
Balance, shares at Sep. 30, 2020 8 2,189 50 24,298,333